Etiology of Bronchopulmonary Dysplasia: Before Birth

被引:1
作者
Zeitlin, Pamela L. [1 ]
Nogee, Lawrence M. [2 ]
机构
[1] Johns Hopkins Med Inst, Eudowood Div Pediat Resp Sci, Baltimore, MD 21287 USA
[2] Johns Hopkins Med Inst, Div Neonatol, Baltimore, MD 21287 USA
关键词
EXTREMELY PRETERM INFANTS; SURFACTANT PROTEIN-A; INSTITUTES-OF-HEALTH; CHRONIC LUNG-DISEASE; PREMATURE-INFANTS; CYSTIC-FIBROSIS; IN-UTERO; INJURY; GENE; INFLAMMATION;
D O I
10.1089/ped.2011.0074
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
Bronchopulmonary dysplasia affects thousands of infants annually with high attendant morbidity, mortality, and healthcare costs. Respiratory outcomes for preterm infants may be widely disparate even within the same medical center for infants of similar gestational ages. Given the high estimates for the heritability for bronchopulmonary dysplasia as measured at 36 weeks of postmenstrual age, the course of disease for a particular infant is likely heavily influenced by factors that operate prenatally or in the early postnatal period. In this review we discuss the etiologies of lung disease in the premature infant, including in utero, genetic, and epigenetic factors that may influence pulmonary outcomes.
引用
收藏
页码:21 / 25
页数:5
相关论文
共 48 条
  • [41] Bronchopulmonary dysplasia -: Where have all the vessels gone?: Roles of angiogenic growth factors in chronic lung disease
    Thebaud, Bernard
    Abman, Steven H.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2007, 175 (10) : 978 - 985
  • [42] Epidemiology of bronchopulmonary dysplasia
    Van Marter, Linda J.
    [J]. SEMINARS IN FETAL & NEONATAL MEDICINE, 2009, 14 (06) : 358 - 366
  • [43] Role of Ureaplasma Species in Neonatal Chronic Lung Disease: Epidemiologic and Experimental Evidence
    Viscardi, Rose Marie
    Hasday, Jeffrey D.
    [J]. PEDIATRIC RESEARCH, 2009, 65 (05) : 84R - 90R
  • [44] Mycoplasmas and ureaplasmas as neonatal pathogens
    Waites, KB
    Katz, B
    Schelonka, RL
    [J]. CLINICAL MICROBIOLOGY REVIEWS, 2005, 18 (04) : 757 - +
  • [45] Impact of a physiologic definition on bronchopulmonary dysplasia rates
    Walsh, MC
    Yao, Q
    Gettner, P
    Hale, E
    Collins, M
    Hensman, A
    Everette, R
    Peters, N
    Miller, N
    Muran, G
    Auten, K
    Newman, N
    Rowan, G
    Grisby, C
    Arnell, K
    Miller, L
    Ball, B
    McDavid, G
    [J]. PEDIATRICS, 2004, 114 (05) : 1305 - 1311
  • [46] Hsp90 cochaperone Aha1 downregulation rescues misfolding of CFTR in cystic fibrosis
    Wang, Xiaodong
    Venable, John
    LaPointe, Paul
    Hutt, Darren M.
    Koulov, Atanas V.
    Coppinger, Judith
    Gurkan, Cemal
    Kellner, Wendy
    Matteson, Jeanne
    Plutner, Helen
    Riordan, John R.
    Kelly, Jeffery W.
    Yates, John R., III
    Balch, William E.
    [J]. CELL, 2006, 127 (04) : 803 - 815
  • [47] CpG methylation patterns in the IFNγ promoter in naive T cells:: Variations during Th1 and Th2 differentiation and between atopics and non-atopics
    White, Gregory P.
    Hollams, Elysia M.
    Yerkovich, Stephanie T.
    Bosco, Anthony
    Holt, Barbara J.
    Bassami, Mohammad R.
    Kusel, Merci
    Sly, Peter D.
    Holt, Patrick G.
    [J]. PEDIATRIC ALLERGY AND IMMUNOLOGY, 2006, 17 (08) : 557 - 564
  • [48] Evidence of CFTR function in cystic fibrosis after systemic administration of 4-phenylbutyrate
    Zeitlin, PL
    Diener-West, M
    Rubenstein, RC
    Boyle, MP
    Lee, CKK
    Brass-Ernst, L
    [J]. MOLECULAR THERAPY, 2002, 6 (01) : 119 - 126